Impact of pretreatment serum creatinine on outcomes in pancreatic adenocarcinoma.

e15749Background: Pancreatic Adenocarcinoma (PA) is an aggressive malignancy with an estimated 5-year survival of 8.5%. PA was responsible for 7.3% of all cancer deaths in 2018 in the US. We aimed ...